[1]林勇军,熊滨,林忠文.免疫营养支持治疗对早期脓毒症患者血管内皮细胞的作用研究▲[J].内科,2018,13(04):561-564.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.07]
 LIN Yongjun,XIONG Bin,LIN Zhongwen.Effect of immunonutrition support therapy on vascular endothelial cells in patients with early sepsis[J].Internal Medicine of China,2018,13(04):561-564.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.07]
点击复制

免疫营养支持治疗对早期脓毒症患者血管内皮细胞的作用研究▲()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
13卷
期数:
2018年04
页码:
561-564
栏目:
论著
出版日期:
2018-08-13

文章信息/Info

Title:
Effect of immunonutrition support therapy on vascular endothelial cells in patients with early sepsis
文章编号:
1673-7768(2018)04-0561-04
作者:
林勇军1熊滨2林忠文1
1 广西壮族自治区工人医院老年科,南宁市530021;2 广西壮族自治区人民医院重症医学科,南宁市530021
Author(s):
LIN Yongjun1 XIONG Bin2 LIN Zhongwen1
1Department of Geriatrics, Guangxi Zhuang Autonomous Region workers′ Hospital, Nanning 530021, China; 2 Department of Critical Care Medicine, The People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
关键词:
脓毒症治疗免疫营养支持内皮细胞功能
Keywords:
SepsisImmune nutrition support Endothelial cell function
分类号:
R 59;R 543
DOI:
DOI:10.16121/j.cnki.cn45-1347/r.2018.04.07
文献标志码:
A
摘要:
目的观察免疫营养支持治疗对早期脓毒症患者内皮细胞功能及预后的影响。方法选取早期脓毒症患者99例,随机分为对照组(51例)和实验组(48例)。对照组患者予以常规综合治疗及营养支持治疗,实验组患者在对照组治疗的基础上加用ω-3脂肪酸和谷氨酰胺进行免疫营养支持治疗。治疗前及治疗后7 d、28 d,对两组患者的慢性健康状况进行评价(APACHEⅡ);检测比较两组患者白蛋白、前白蛋白、可溶性血栓调节蛋白(sTM)、可溶性E选择素(sE选择素)、血管性假性血友病因子(vwF)、内皮素1(ET-1)水平;比较两组患者28 d内感染性休克及严重脓毒症的发生率及病死率。结果治疗28 d后,实验组患者存活38例,对照组患者存活37例。治疗前、治疗后7 d、28 d,两组患者的白蛋白、前白蛋白、降钙素原水平及APACHEⅡ评分比较差异均有统计学意义(P<0.05),两种治疗方法对患者的白蛋白、前白蛋白、降钙素原水平及APACHEⅡ评分的影响存在差异,治疗方法与治疗时间存在交互作用;两组患者的sTM、sE选择素、vwF、ET-1水平比较差异均有统计学意义(P<0.01),两种治疗方法对患者的sTM、sE选择素、vwF、ET-1水平的影响存在差异,治疗方法与治疗时间存在交互作用。实验组患者的感染性休克或严重脓毒症的发生率和病死率略高于对照组,但差异无统计学意义(P>0.05)。结论免疫营养支持治疗可有效改善早期脓毒症患者的血管内皮细胞功能,纠正患者的不良营养状态,有效缓解病情,但其对患者预后的影响尚有待进一步观察。
Abstract:
ObjectiveTo observe the effect of immunonutrition support therapy on endothelial cell function and prognosis in patients with early sepsis. Methods99 patients with early sepsis were randomly divided into control group (51 cases) and experimental group (48 cases). Patients in the control group were treated with conventional comprehensive treatment and nutritional support. The patients in the experimental group were treated with omega-3 fatty acids and glutamine for immunonutrition support treatment based on the control group. The chronic health status of the two groups was evaluated before and after 7 days and 4 weeks of treatment (APACHE II). The total protein, albumin, prealbumin, soluble thrombomodulin (sTM), soluble E-selectin (sE selectin), von Willebrand factor (vwF), and endothelin 1 were compared between the two groups. ET-1) level. The incidence and mortality of septic shock and severe sepsis were compared between the two groups within 4 weeks. ResultsAfter 28 days treatment,there were 38 patients survived in experimental group and 37 patients survived in control group.Before and 7,28 days after treatment, there were significant differences in albumin, prealbumin, procalcitonin levels and APACHE II scores between the two groups (P<0.05).The effects of the two treatments on the levels of albumin, prealbumin, procalcitonin levels and APACHE II scores were statistic different, and there was an interaction between treatment and time.There were significant differences in levels of sTM, sE selectin, vwF and ET-1 between the two groups (P<0.01),the effects of the two treatments on the levels of sTM, sE selectin, vwF, and ET-1 were statistic different, and there was an interaction between treatment and time.The incidence and fatality rate of septic shock or severe sepsis in experimental group were a little bit higher than those in control group,but there were no significant differences (P>0.05). ConclusionImmunonutrition support treatment can effectively improve the vascular endothelial cell function in patients with early sepsis, correct the patient′s adverse nutritional status, and effectively alleviate the disease, but its impact on the prognosis of patients remains to be further observed.However, its impact on the prognosis of patients remains to be further observed.

相似文献/References:

[1]华占楼,孙继妹,谢金春,等.早期小剂量地塞米松对急性胰腺炎治疗效果的影响[J].内科,2014,(05):531.
 HUA Zhan lou,SUN Ji mei,XIE Jin chun.Treatment effect of small dosage of dexamethsone in patients with acute pancreatitis in the early time[J].Internal Medicine of China,2014,(04):531.
[2]刘昌灵,何明璋.常规疗法联用盐酸帕罗西汀治疗功能性消化不良的疗效观察[J].内科,2014,(05):534.
 LIU Chang ling,HE Ming zhang.Therapeutic effect of the conventional therapy plus paroxetine on the functional dyspepsia[J].Internal Medicine of China,2014,(04):534.
[3]洪长发.阿奇霉素联合头孢曲松治疗社区获得性肺炎疗效观察[J].内科,2014,(05):546.
[4]骆振波.炎琥宁治疗流行性腮腺炎66例临床疗效观察[J].内科,2014,(05):548.
[5]张喜民,刘文智,豆永强,等.胺碘酮治疗心力衰竭合并室性心律失常63例临床疗效观察[J].内科,2014,(05):552.
[6]莫小琼,蓝惠珍,莫如珍,等.血液透析滤过治疗尿毒症顽固性高血压的疗效观察与护理[J].内科,2014,(05):588.
[7]陶林.曲美他嗪治疗缺血性心肌病心力衰竭30例疗效观察[J].内科,2015,(01):11.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.04]
 [J].Internal Medicine of China,2015,(04):11.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.04]
[8]胡文标.曲美他嗪治疗缺血性心肌病心力衰竭疗效观察[J].内科,2015,(01):13.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.05]
 [J].Internal Medicine of China,2015,(04):13.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.05]
[9]王普.厄贝沙坦治疗轻、中度高血压患者24例的临床疗效观察[J].内科,2015,(01):17.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.07]
 [J].Internal Medicine of China,2015,(04):17.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.07]
[10]陆红梅 朱春燕 包守丽.多功能无创正压通气治疗COPD并发肺性脑病的疗效观察[J].内科,2015,(01):31.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.13]
 [J].Internal Medicine of China,2015,(04):31.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.13]
[11]赵旭兵.美罗培南联合小剂量糖皮质激素治疗脓毒症休克患者临床观察[J].内科,2018,13(05):786.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.05.34]
 [J].Internal Medicine of China,2018,13(04):786.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.05.34]

备注/Memo

备注/Memo:
▲基金项目:广西壮族自治区卫生厅科研课题(Z2012298);“广西急诊与医学救援人才小高地·广西高校急诊医学重点实验室”开放课题(GXJZ201617)
更新日期/Last Update: 2018-08-14